Residential College | false |
Status | 已發表Published |
Editorial: Progress of programmed cell death in antitumor immunity | |
Yan FangFang1; Mao Chao2; Leung Elaine Lai Han3; Luo LianXiang4 | |
2023 | |
Media | Frontiers in Immunology |
DOI | 10.3389/fimmu.2023.1230490 |
Keyword | Cancer Ferroptosis Immune Checkpoint Inhibitors Immunotherapy Regulated Cell Death Tumor Microenvironment |
Language | 英語English |
URL | View the original |
Scopus ID | 2-s2.0-85163635349 |
Fulltext Access | |
Citation statistics | |
Document Type | Other |
Collection | DEPARTMENT OF BIOMEDICAL SCIENCES INSTITUTE OF COLLABORATIVE INNOVATION |
Corresponding Author | Leung Elaine Lai Han; Luo LianXiang |
Affiliation | 1.The First Clinical College,Guangdong Medical University,Zhanjiang,China 2.Department of Experimental Radiation Oncology,The University of Texas MD Anderson Cancer Center,Houston,United States 3.Cancer Center,Faculty of Health Science,Ministry of Education (MOE) Frontiers Science Center for Precision Oncology,University of Macau,Macao 4.The Marine Biomedical Research Institute,Guangdong Medical University,Zhanjiang,China |
Recommended Citation GB/T 7714 | Yan FangFang,Mao Chao,Leung Elaine Lai Han,et al. Editorial: Progress of programmed cell death in antitumor immunity. 2023-01-01. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment